Actionable news
0
All posts from Actionable news
Actionable news in HUM: HUMANA Inc,

Prospectuses and communications, business combinations

BGCOLOR="WHITE">

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Humana Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

502-580-1000

(Registrants Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

Humana Inc. (Humana) today reaffirmed its guidance of approximately $7.75 and $2.15 in adjusted earnings per common share (Adjusted EPS) for the year ending December 31, 2015 and for the quarter ended September 30, 2015, respectively. This guidance is consistent with that last issued in Humanas earnings press release dated July 29, 2015 and, as discussed in that press release, now also incorporates adjustments for expenses associated with the previously disclosed proposed transaction with Aetna Inc. (Aetna).

Humanas Adjusted EPS guidance for the full year 2015 excludes a pretax gain of approximately $267 million, or $1.53 per share, associated with the completion of Humanas sale of its wholly-owned subsidiary, Concentra Inc., recognized in the first half of 2015. Additionally, Adjusted EPS for both the full year 2015 and the quarter ended September 30, 2015 exclude estimated transaction-related costs of approximately $17 million pretax, or $0.10 per share, and approximately $11 million pretax, or $0.07 per share, respectively. Certain costs associated with the transaction are not deductible for income tax purposes.

Humana has included this financial measure (which is not in accordance with Generally Accepted Accounting Principles (GAAP)) as management believes that this measure, when presented in conjunction with the comparable GAAP measure, is useful to both management and its investors in analyzing the companys ongoing business and operating performance. The excluded items described herein are not a recurring part of the companys operating plan. Consequently, management uses this non-GAAP financial measure as an indicator of business performance, as well as for operational planning and decision making purposes...


More